John Militello - 13 Feb 2026 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role: Vice President of Finance, Treasurer, Principal Accounting Officer
Signature: /s/ Martin Wilson, as attorney-in-fact for John Militello
Issuer symbol: RCKT
Transactions as of: 13 Feb 2026
Net transactions value: -$12,341
Form type: 4
Filing time: 18 Feb 2026, 17:38:28 UTC
Previous filing: 13 Feb 2026
Next filing: 20 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Militello John	Vice President of Finance, Treasurer, Principal Accounting Officer	C/O ROCKET PHARMACEUTICALS, INC., 9 CEDARBROOK DRIVE, CRANBURY	/s/ Martin Wilson, as attorney-in-fact for John Militello	18 Feb 2026	0001662170

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RCKT	Common Stock	Sale	$12,341	-3,726	-3.9%	$3.31	92,176	13 Feb 2026	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
F2	The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.

Remarks:

Vice President of Finance, Treasurer, Principal Accounting Officer